[CSII] Cardiovascular Systems, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization: 617.46 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 25.79 Change: 0.6 (2.38%)

chart CSII

Refresh chart

Strongest Trends Summary For CSII

CSII is in the long-term up 73% in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and markets devices for the treatment of vascular diseases. Its products include catheter-based platforms, such as the Stealth 360° Peripheral Orbital Atherectomy System (OAS), Diamondback 360 Peripheral OAS, Stealth 360° peripheral artery disease (PAD) System, Diamondback 360° PAD System, and Diamondback Predator 360° PAD System that are used for the treatment of a range of plaque types in leg arteries above and below the knee. The company markets its products through direct sales force to hospitals and office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding32.67 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 18.81% Sales Growth - Q/Q5.08% P/E
P/E To EPS Growth P/S3.58 P/BV4.33 Price/Cash Per Share
Price/Free Cash Flow-15.61 ROA-18.91% ROE-23.67% ROI
Current Ratio4.19 Quick Ratio3.8 Long Term Debt/Equity Debt Ratio0.24
Gross Margin78.13% Operating Margin-19.43% Net Profit Margin-19.57% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities930 K Cash From Investing Activities-18.96 M Cash From Operating Activities-15.09 M Gross Profit36.59 M
Net Profit-10.66 M Operating Profit-10.54 M Total Assets178.63 M Total Current Assets141.83 M
Total Current Liabilities33.88 M Total Debt Total Liabilities35.89 M Total Revenue47 M
Technical Data
High 52 week38.55 Low 52 week21.05 Last close38.21 Last change-0.83%
RSI71.05 Average true range0.77 Beta0.57 Volume165.06 K
Simple moving average 20 days0.63% Simple moving average 50 days6.16% Simple moving average 200 days36.51%
Performance Data
Performance Week-0.08% Performance Month3.21% Performance Quart26.44% Performance Half53.27%
Performance Year21.69% Performance Year-to-date61.29% Volatility daily0.73% Volatility weekly1.63%
Volatility monthly3.33% Volatility yearly11.54% Relative Volume181.35% Average Volume300.7 K
New High New Low

News

2019-03-14 09:12:01 | Cardiovascular Systems Gains on Global Growth & Innovation

2019-03-11 14:50:30 | How Much is Cardiovascular Systems, Inc.’s NASDAQ:CSII CEO Getting Paid?

2019-03-04 16:05:00 | Cardiovascular Systems, Inc. to Present at Three Upcoming Investor Conferences

2019-03-01 17:55:00 | Washington Real Estate Investment Trust and Cardiovascular Systems Set to Join S&P SmallCap 600

2019-02-28 10:49:03 | Merit Medical MMSI Q4 Earnings & Revenues Surpass Estimates

2019-02-27 09:08:02 | Veeva Systems VEEV Beats on Q4 Earnings and Revenues

2019-02-27 08:19:01 | Wright Medical WMGI Q4 Earnings & Revenues Beat Estimates

2019-02-26 18:04:11 | Bruker Rides on Robust NANO & CALID Groups, Recent Buyouts

2019-02-26 17:58:10 | Here's Why Investors Should Buy DexCom DXCM Stock Now

2019-02-25 08:02:01 | CVS Health Rides on Aetna Synergy, PBM Selling Season Modest

2019-02-22 09:16:02 | Here's Why Investors Should Hold DaVita DVA Stock Now

2019-02-21 09:28:02 | Medidata's MDSO Margins Under Pressure, Competition Rife

2019-02-20 07:00:00 | Cardiovascular Systems, Inc. to Present at the 8th Annual SVB Leerink Global Healthcare Conference

2019-02-19 09:15:02 | Here's Why Investors Should Buy Surmodics SRDX Stock Now

2019-02-19 08:10:00 | New Research: Key Drivers of Growth for Omega Healthcare Investors, Cinedigm, Cardiovascular, Allegiant Travel, Catalyst Biosciences, and ESCO Technologies — Factors of Influence, Major Initiatives and Sustained Production

2019-02-15 09:33:02 | Here's Why You Must Buy Cardiovascular Systems' CSII Stock

2019-02-14 09:07:02 | Baxter's Acute Therapies Profile Strong, Competition Rife

2019-02-13 08:16:01 | Here's Why Investors Should Retain AmerisourceBergen Stock

2019-02-12 09:48:02 | Here's Why Investors Should Retain Accuray ARAY Stock Now

2019-02-11 08:41:01 | Here's Why You Should Buy Wright Medical WMGI Stock Now

2019-02-06 09:56:02 | Here's Why You Should Invest in McKesson MCK Stock Now

2019-02-04 16:40:09 | Here's Why You Should Hold Intuitive Surgical ISRG Stock

2019-02-01 09:55:02 | Cardiovascular Systems CSII Q2 Earnings Top, Revenues Meet

2019-01-31 09:30:02 | Company News For Jan 31, 2019

2019-01-30 22:32:39 | Edited Transcript of CSII earnings conference call or presentation 30-Jan-19 9:30pm GMT

2019-01-30 17:25:10 | Cardiovascular Systems CSII Surpasses Q2 Earnings and Revenue Estimates

2019-01-30 16:16:19 | Cardiovascular Systems: Fiscal 2Q Earnings Snapshot

2019-01-30 16:05:00 | Cardiovascular Systems, Inc. Reports Fiscal 2019 Second-Quarter Financial Results

2019-01-29 13:04:45 | Is Cardiovascular Systems, Inc. NASDAQ:CSII Struggling With Its 0.6% Return On Capital Employed?

2019-01-16 16:05:00 | First Patients in the Middle East Treated with Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System

2019-01-07 10:57:03 | Cardiovascular Systems Expands Portfolio Amid Stiff Rivalry

2019-01-07 07:00:00 | Cardiovascular Systems, Inc. Announces Preliminary Fiscal 2019 Second-Quarter Revenues of $60.2 Million

2019-01-02 07:00:00 | Cardiovascular Systems, Inc. Receives Approval for the Diamondback 360® Coronary Orbital Atherectomy System with Classic Crown and New ViperWire Advance® FlexTip Guidewire in Japan

2018-12-31 08:45:01 | Cardiovascular Systems Treats First Patient With Teleport

2018-12-26 16:05:00 | Cardiovascular Systems, Inc. Announces First Patients Treated in United States with OrbusNeich Teleport® Microcatheter

2018-12-13 08:39:06 | Is Cardiovascular Systems Inc CSII A Good Stock To Buy?

2018-12-11 13:59:00 | Are Cardiovascular Systems, Inc.’s NASDAQ:CSII Interest Costs Too High?

2018-11-28 07:50:00 | Analysis: Positioning to Benefit within Cardiovascular, Ennis, Sparton, LightPath Technologies, Blue Apron, and HFF — Research Highlights Growth, Revenue, and Consolidated Results

2018-11-13 16:05:00 | First Patients in Europe Treated with Cardiovascular Systems, Inc. Peripheral Orbital Atherectomy System

2018-11-08 07:00:00 | First Patient in Hong Kong Treated with Cardiovascular Systems, Inc. Coronary Orbital Atherectomy System

2018-10-31 10:52:02 | Cardiovascular Systems' CSII Q1 Loss Wider Than Expected

2018-10-30 22:04:57 | Edited Transcript of CSII earnings conference call or presentation 30-Oct-18 8:45pm GMT

2018-10-30 19:25:11 | Cardiovascular Systems CSII Reports Q1 Loss, Tops Revenue Estimates

2018-10-30 18:19:42 | Cardiovascular Systems: Fiscal 1Q Earnings Snapshot

2018-10-30 16:05:00 | Cardiovascular Systems, Inc. Reports Fiscal 2019 First-Quarter Financial Results

2018-10-23 10:32:02 | Cardiovascular Systems CSII Q1 Earnings Preview: What's Shaping Up?

2018-10-18 08:00:00 | Report: Exploring Fundamental Drivers Behind Continental Building Products, Hornbeck Offshore Services, Digi International, Triple-S Management, Collegium Pharmaceutical, and Cardiovascular — New Horizons, Emerging Trends, and Upcoming Developments

2018-10-09 07:00:00 | Cardiovascular Systems, Inc. to Webcast Fiscal 2019 First-Quarter Earnings Conference Call Tuesday, October 30

2018-10-05 11:17:47 | Who Are Cardiovascular Systems Inc’s NASDAQ:CSII Major Shareholders?

2018-09-20 08:17:12 | Cardiovascular Systems Stealth 360 Peripheral OAS Goes Global